Effect of Alendronate and Vitamin D 3 Treatment on Bone Turnover Markers in Postmenopausal Women with High Fracture Risk: a Double-blind, Randomized Controlled Trial.

Files in this item

This item appears in the following Collection(s)

Search DSpace


Browse

My Account